BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16013043)

  • 21. Effects of social rank and pubertal delay on brain structure in female rhesus macaques.
    Godfrey JR; Howell BR; Mummert A; Shi Y; Styner M; Wilson ME; Sanchez M
    Psychoneuroendocrinology; 2023 Mar; 149():105987. PubMed ID: 36529113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in Sex-Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism.
    Ortega RA; Bressman SB; Raymond D; Ozelius LJ; Katsnelson V; Leaver K; Swan MC; Shanker V; Miravite J; Wang C; Bennett SAL; Saunders-Pullman R
    Mov Disord; 2022 Nov; 37(11):2217-2225. PubMed ID: 36054306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen Up-Regulates Iron Transporters and Iron Storage Protein Through Hypoxia Inducible Factor 1 Alpha Activation Mediated by Estrogen Receptor β and G Protein Estrogen Receptor in BV2 Microglia Cells.
    Qu Y; Li N; Xu M; Zhang D; Xie J; Wang J
    Neurochem Res; 2022 Dec; 47(12):3659-3669. PubMed ID: 35829942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in stress-induced alcohol intake: a review of preclinical studies focused on amygdala and inflammatory pathways.
    Mineur YS; Garcia-Rivas V; Thomas MA; Soares AR; McKee SA; Picciotto MR
    Psychopharmacology (Berl); 2022 Jul; 239(7):2041-2061. PubMed ID: 35359158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast Growth Factor 21 Modulates Microglial Polarization That Attenuates Neurodegeneration in Mice and Cellular Models of Parkinson's Disease.
    Yang C; Wang W; Deng P; Li C; Zhao L; Gao H
    Front Aging Neurosci; 2021; 13():778527. PubMed ID: 35002679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-specific effects of developmental exposure to polychlorinated biphenyls on neuroimmune and dopaminergic endpoints in adolescent rats.
    Liberman DA; Walker KA; Gore AC; Bell MR
    Neurotoxicol Teratol; 2020; 79():106880. PubMed ID: 32259577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis.
    Çakici N; van Beveren NJM; Judge-Hundal G; Koola MM; Sommer IEC
    Psychol Med; 2019 Oct; 49(14):2307-2319. PubMed ID: 31439071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke and the neurovascular unit: glial cells, sex differences, and hypertension.
    Morrison HW; Filosa JA
    Am J Physiol Cell Physiol; 2019 Mar; 316(3):C325-C339. PubMed ID: 30601672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in effects of gestational polychlorinated biphenyl exposure on hypothalamic neuroimmune and neuromodulator systems in neonatal rats.
    Bell MR; Dryden A; Will R; Gore AC
    Toxicol Appl Pharmacol; 2018 Aug; 353():55-66. PubMed ID: 29879404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microglia activation triggers oligodendrocyte precursor cells apoptosis via HSP60.
    Li Y; Zhang R; Hou X; Zhang Y; Ding F; Li F; Yao Y; Wang Y
    Mol Med Rep; 2017 Jul; 16(1):603-608. PubMed ID: 28586011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immune system as a novel regulator of sex differences in brain and behavioral development.
    Nelson LH; Lenz KM
    J Neurosci Res; 2017 Jan; 95(1-2):447-461. PubMed ID: 27870450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective Microglia and Their Regulation in Parkinson's Disease.
    Le W; Wu J; Tang Y
    Front Mol Neurosci; 2016; 9():89. PubMed ID: 27708561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery at the interface: Toward novel anti-proliferative agents targeting human estrogen receptor/S100 interactions.
    Lee DH; Asare BK; Rajnarayanan RV
    Cell Cycle; 2016 Oct; 15(20):2806-18. PubMed ID: 27580430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in Parkinson's disease.
    Gillies GE; Pienaar IS; Vohra S; Qamhawi Z
    Front Neuroendocrinol; 2014 Aug; 35(3):370-84. PubMed ID: 24607323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.
    Sommer IE; van Westrhenen R; Begemann MJ; de Witte LD; Leucht S; Kahn RS
    Schizophr Bull; 2014 Jan; 40(1):181-91. PubMed ID: 24106335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke neuroprotection: oestrogen and insulin-like growth factor-1 interactions and the role of microglia.
    Sohrabji F; Williams M
    J Neuroendocrinol; 2013 Nov; 25(11):1173-81. PubMed ID: 23763366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effects of estradiol on motoneurons in a model of rat spinal cord embryonic explants.
    Cardona-Rossinyol A; Mir M; Caraballo-Miralles V; Lladó J; Olmos G
    Cell Mol Neurobiol; 2013 Apr; 33(3):421-32. PubMed ID: 23322321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.
    McArthur S; Gillies GE
    Front Endocrinol (Lausanne); 2011; 2():82. PubMed ID: 22649388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke.
    Ritzel RM; Capozzi LA; McCullough LD
    Horm Behav; 2013 Feb; 63(2):238-53. PubMed ID: 22561337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy and risk for neurodegenerative diseases.
    Dye RV; Miller KJ; Singer EJ; Levine AJ
    Int J Alzheimers Dis; 2012; 2012():258454. PubMed ID: 22548198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.